Louis Sene
Vice President, Investor Relations
Replay available
Novavax, Inc. (NASDAQ: NVAX) Q3 2025 earnings conference call, held 2025-11-06. Replay captured from the company's public earnings webcast.

Vice President, Investor Relations
President and CEO
Head of R&D
Chief Financial Officer and Treasurer
Analyst, B. Riley Securities
Analyst, Cantor Fitzgerald
Analyst, TD Securities
Analyst, Bank of America
Watch the replay and follow the connected company analysis, news, and investor updates for Novavax, Inc..
WEBVTT 00:00:00.031 -- 00:00:05.276 Good morning and welcome to Novavax third quarter 2025 financial results 00:00:05.276 -- 00:00:07.918 and operational highlights conference call. 00:00:07.918 -- 00:00:10.000 All participants will be in a listen-only mode. 00:00:10.000 -- 00:00:13.984 Should you need assistance, please signal a conference specialist by pressing the star 00:00:13.984 -- 00:00:18.668 key followed by zero. After today's presentation, there will be an opportunity to ask 00:00:18.668 -- 00:00:23.473 questions. To ask a question, you may press star and then the digit one on your touch-tone 00:00:23.473 -- 00:00:27.925 phone. To withdraw your question, repeat the steps of star and one. 00:00:27.925 -- 00:00:31.648 Please note, this event is being recorded, and I would now like to turn the conference 00:00:31.648 -- 00:00:35.072 over to Louis Sene, Vice President, Investor Relations. 00:00:35.072 -- 00:00:37.692 Please go ahead, sir. 00:00:39.055 -- 00:00:44.020 Good morning, and thank you all for joining us today to discuss our third quarter 2025 00:00:44.020 -- 00:00:47.483 financial results and operational highlights. 00:00:47.483 -- 00:00:53.068 A press release announcing our results is available on our website at Novavax.com, 00:00:53.068 -- 00:00:58.958 and an audio archive of this conference call will be available on our website later today. 00:00:58.958 -- 00:01:04.267 Please turn to slide two. Before we begin with prepared remarks, I need to remind 00:01:04.267 -- 00:01:09.357 you that this presentation includes forward-looking statements, including but not limited 00:01:09.357 -- 00:01:14.726 to statements related to Novavax's corporate strategy and operating plans, 00:01:14.726 -- 00:01:20.116 its strategic priorities, its partnerships, and expe...